Results 41 to 50 of about 18,093 (282)

Severe B Cell Deficiency in Mice Lacking the Tec Kinase Family Members Tec and Btk [PDF]

open access: yes, 2000
The cytoplasmic protein tyrosine kinase Tec has been proposed to have important functions in hematopoiesis and lymphocyte signal transduction. Here we show that Tec-deficient mice developed normally and had no major phenotypic alterations of the immune ...
Baltimore, David   +7 more
core   +3 more sources

Community-acquired Acinetobacter calcoaceticus pneumonia in a patient with agammaglobulinaemia

open access: yesNew Microbes and New Infections, 2021
We herein describe the case of a 38-year-old patient with congenital agammaglobulinemia who presented with community-acquired pneumonia; acute respiratory failure with sepsis ensued requiring ICU admission, mechanical ventilation and vasopressors ...
K. El Gharib   +3 more
doaj   +1 more source

Good's Syndrome Presenting With Weaning Failure From Ventilation and Myasthenia Gravis in a Post-Thymectomy Patient. [PDF]

open access: yesRespirol Case Rep
This case highlights the importance of long‐term vigilance in patients with thymoma, even after apparently successful resection, as Good's syndrome may manifest years later. Clinicians should maintain a high index of suspicion for Good's syndrome in any thymectomized patient presenting with unexplained infections, diarrhoea, or autoimmune complications,
Mehta AA   +4 more
europepmc   +2 more sources

Genetic stability of Campylobacter coli in patients with primary antibody deficiencies [PDF]

open access: yes, 2019
In the Clinical Communication, Dion et al 1 reported that in patients with severe primary antibody deficiency (PAD), Campylobacter infection is a major cause (6.5%) of chronic or recurrent diarrhea. Moreover, by a molecular study performed in a subset of
Milito, Cinzia, Quinti, Isabella
core   +1 more source

Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India

open access: yesFrontiers in Immunology, 2021
Background There is paucity of literature on XLA from developing countries. Herein we report the clinical and molecular profile and outcome in a multicenter cohort of patients with XLA from India.
A. Rawat   +41 more
semanticscholar   +1 more source

Clinic of humoral primary immunodeficiencies in adults. Experience in a tertiary hospital

open access: yesRevista Alergia México, 2016
Background: Primary immunodeficiencies (PID) are characterized by alteration of the components of the immune system. Humoral deficiencies represent 50%.
Julio César Cambray-Gutiérrez   +3 more
doaj   +1 more source

Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia [PDF]

open access: yes, 2014
BACKGROUND: Patients with X-linked agammaglobulinemia (XLA) develop immune-complex induced diseases such as nephropathy only rarely, presumably because their immunoglobulin (Ig) G concentration is low.
Akane Izu   +7 more
core   +2 more sources

Haematopoietic Stem Cell Transplant for Norovirus-Induced Intestinal Failure in X-linked Agammaglobulinemia

open access: yesJournal of Clinical Immunology, 2021
Since the first clinical description in 1952, immunoglobulin replacement therapy remains the mainstay of treatment of patients with X-linked agammaglobulinemia (XLA). However, this therapy only replaces IgG isotype and does not compensate for the loss of
B. Shillitoe   +8 more
semanticscholar   +1 more source

Fatal SARS in X-Linked Lymphoproliferative Disease Type 1: A Case Report

open access: yesFrontiers in Pediatrics, 2022
X-linked lymphoproliferative disease (XLP1) is an inborn error of immunity (IEI) with severe immune dysregulation caused by a mutation in the SH2D1A gene resulting in the absence or dysfunction of signaling lymphocytic activation molecule (SLAM ...
Ming Hin Chung   +5 more
doaj   +1 more source

Targeting Brutons Tyrosine Kinase in Chronic Lymphocytic Leukemia at the Crossroad between Intrinsic and Extrinsic Pro-survival Signals [PDF]

open access: yes, 2016
Chemo immunotherapies for chronic lymphocytic leukemia (CLL) showed a positive impact on clinical outcome, but many patients relapsed or become refractory to the available treatments.
Facco, Monica   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy